Prevention of progression in chronic liver disease : an update on SNMC (stronger neo-minophagen C) : in honour of Hans Popper's 100th birthday

著者

    • Falk Workshop (2003 : Freiburg, Germany)
    • Manns, Marianne
    • Hayashi, N. (Nariyuki)
    • Falk Liver Week (12th : 2003 : Freiburg, Germany)

書誌事項

Prevention of progression in chronic liver disease : an update on SNMC (stronger neo-minophagen C) : in honour of Hans Popper's 100th birthday

edited by N. Hayashi, M.P. Manns

（Falk symposium, 138A）

Kluwer Academic Publishers, c2004

大学図書館所蔵 件 / 全4件

この図書・雑誌をさがす

注記

"Proceedings of the Falk Workshop (Part IV of the XII Falk Liver Week) held in Freiburg, Germany, October 22, 2003"--T.p.

Includes bibliographical references and index

内容説明・目次

内容説明

In several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40% of patients with HCV genotype 1 and up to 20% of patients with genotype 2 or 3. Several approaches are now underway to prevent or ameliorate mechanisms of disease progression. In Asia, and particularly in Japan, Glycyrrhizine-SNMC has been widely used for this purpose. At present, SNMC is under clinical evaluation in Europe.

目次

  • List of Principal Authors. Preface. Introduction
  • H Suzuki. 1: Mechanisms of fibrogenesis
  • B Stefanovic, J Lindquist, RA Rippe, B Schnabl, R Schwabe, R Bataller, DA Brenner. 2: Non-invasive markers of liver injury
  • V Ratziu, T Poynard. 3: Complications of cirrhosis: the relevance of hepatocellular carcinoma
  • M Colombo, M Iavarone. 4: Controlling necroinflammation of liver with SNMC (Stronger Neo Minophagen C): therapy on interferon non-responders
  • S Lino. 5: Predictive parameters of non-response to standard hepatitis treatment
  • H Wedemeyer. 6: Concepts for the treatment of non-responders in hepatitis C
  • S Zeuzem. 7: Glycyrrhizin: the molecule and present knowledge of action in various liver diseases
  • K Shiraki, H Sato, M Kurokawa, Y Yoshida. 8: Dendritic cells in immune responses against hepatitis C virus
  • N Hayashi, T Kanto, T Takehara. 9: SNMC in the prevention of cirrhosis and hepatocellular carcinoma: Japanese experience
  • K Ikeda. 10: SNMC in interferon non-responders with chronic hepatitis C: European experience in controlled trials
  • S Schalm, TGF van Rossum, H Orlent, BE Hansen. Index

「Nielsen BookData」 より

関連文献： 1件中  1-1を表示

詳細情報

ページトップへ